Skip to main content
Interview with the Innovators

Chaitali Nangia, MD, on the Approval of ORSERDU™

Chaitali Nangia, MD
Medical Oncologist
Hoag Medical Group | Irvine, CA

Dr Nangia, medical oncologist at Hoag Medical Group in Irvine, CA, discusses key efficacy and safety data from the EMERALD trial, the importance of liquid biopsy testing, and changes in practice brought upon by the approval of ORSERDU (elacestrant).

Related Items